Michael V. Ortiz

1.8k total citations
52 papers, 682 citations indexed

About

Michael V. Ortiz is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, Michael V. Ortiz has authored 52 papers receiving a total of 682 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 16 papers in Pulmonary and Respiratory Medicine and 13 papers in Neurology. Recurrent topics in Michael V. Ortiz's work include Sarcoma Diagnosis and Treatment (9 papers), Renal and related cancers (7 papers) and Neuroblastoma Research and Treatments (6 papers). Michael V. Ortiz is often cited by papers focused on Sarcoma Diagnosis and Treatment (9 papers), Renal and related cancers (7 papers) and Neuroblastoma Research and Treatments (6 papers). Michael V. Ortiz collaborates with scholars based in United States, Spain and Switzerland. Michael V. Ortiz's co-authors include Ira J. Dunkel, Alex Kentsis, Neerav Shukla, Julia Glade Bender, Stephen S. Roberts, Jackson D. Harvey, Hanan Baker, Leonard H. Wexler, Daniel A. Heller and Fernando Vidal and has published in prestigious journals such as Journal of Clinical Oncology, PEDIATRICS and PLANT PHYSIOLOGY.

In The Last Decade

Michael V. Ortiz

44 papers receiving 667 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael V. Ortiz United States 15 297 109 106 99 86 52 682
Yuqiang Fang China 17 398 1.3× 132 1.2× 73 0.7× 71 0.7× 73 0.8× 39 761
Masahiko Tanabe Japan 15 323 1.1× 290 2.7× 147 1.4× 29 0.3× 140 1.6× 90 882
Megha S. Uppin India 13 200 0.7× 54 0.5× 52 0.5× 10 0.1× 107 1.2× 57 549
Mohd Hafeez Faridi United States 15 263 0.9× 109 1.0× 99 0.9× 8 0.1× 78 0.9× 20 865
Adam L. Green United States 19 376 1.3× 137 1.3× 45 0.4× 7 0.1× 121 1.4× 55 923
M. Mandel Israel 16 172 0.6× 94 0.9× 19 0.2× 21 0.2× 109 1.3× 30 680
Sajeel Chowdhary United States 14 204 0.7× 163 1.5× 87 0.8× 9 0.1× 185 2.2× 47 819
Kousuke Watanabe Japan 16 403 1.4× 143 1.3× 46 0.4× 10 0.1× 148 1.7× 56 695
Fatéméh Dubois France 14 314 1.1× 107 1.0× 57 0.5× 8 0.1× 101 1.2× 39 811
Kazuya Hirano Japan 18 449 1.5× 134 1.2× 101 1.0× 6 0.1× 183 2.1× 41 871

Countries citing papers authored by Michael V. Ortiz

Since Specialization
Citations

This map shows the geographic impact of Michael V. Ortiz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael V. Ortiz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael V. Ortiz more than expected).

Fields of papers citing papers by Michael V. Ortiz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael V. Ortiz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael V. Ortiz. The network helps show where Michael V. Ortiz may publish in the future.

Co-authorship network of co-authors of Michael V. Ortiz

This figure shows the co-authorship network connecting the top 25 collaborators of Michael V. Ortiz. A scholar is included among the top collaborators of Michael V. Ortiz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael V. Ortiz. Michael V. Ortiz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Geller, James I., Michael V. Ortiz, David Walterhouse, et al.. (2025). Anti‐Tumor Activity of Paclitaxel‐Containing Regimens in Recurrent/Refractory Wilms Tumor. Pediatric Blood & Cancer. 72(10). e31915–e31915.
3.
Casey, Dana L., Kathryn R. Tringale, Michael P. LaQuaglia, et al.. (2024). Intraoperative radiation therapy for pediatric sarcomas and other solid tumors. Pediatric Blood & Cancer. 71(6). e30949–e30949.
4.
Ortiz, Michael V., Christa Koenig, Amy E. Armstrong, et al.. (2023). Advances in the clinical management of high‐risk Wilms tumors. Pediatric Blood & Cancer. 70(S2). e30342–e30342. 7 indexed citations
5.
Ortiz, Michael V., Christa Koenig, Amy E. Armstrong, et al.. (2023). Advances in the clinical management of high‐risk Wilms tumors. Pediatric Blood & Cancer. 70(3). 8 indexed citations
6.
McClure, Barbara J., Michael V. Ortiz, Michael S. Samuel, et al.. (2023). Desmoglein-2 as a cancer modulator: friend or foe?. Frontiers in Oncology. 13. 1327478–1327478. 3 indexed citations
7.
Lalazar, Gadi, Guangrong Zheng, Peiyi Zhang, et al.. (2022). Targeting BCL-XL in fibrolamellar hepatocellular carcinoma. JCI Insight. 7(17). 18 indexed citations
8.
Armstrong, Katherine, Audrey Mauguen, Emily K. Slotkin, et al.. (2022). Chemotherapy‐induced thrombocytopenia in pediatric oncology: Scope of the problem and opportunities for intervention. Pediatric Blood & Cancer. 69(10). e29776–e29776. 3 indexed citations
9.
Berlow, Noah, Michael V. Ortiz, Filemon S. Dela Cruz, et al.. (2021). Bromodomain 4 inhibition leads to MYCN downregulation in Wilms tumor. Pediatric Blood & Cancer. 69(2). e29401–e29401. 8 indexed citations
10.
Bouvier, Nancy, Jinru Shia, Anita P. Price, et al.. (2021). Identification of a TP53 Deletion in an Undifferentiated Embryonal Sarcoma of the Liver Provides Clinically Relevant Longitudinal Detection of Circulating Tumor DNA. JCO Precision Oncology. 5(5). 1421–1425. 1 indexed citations
11.
Mathias, Melissa, Michael V. Ortiz, Kay See Tan, et al.. (2019). Local Anesthesia With General Anesthesia for Pediatric Bone Marrow Procedures. PEDIATRICS. 144(2). 3 indexed citations
12.
Ortiz, Michael V., Stephen S. Roberts, Julia Glade Bender, Neerav Shukla, & Leonard H. Wexler. (2019). Immunotherapeutic Targeting of GPC3 in Pediatric Solid Embryonal Tumors. Frontiers in Oncology. 9. 108–108. 53 indexed citations
13.
Nicholson, Laura, et al.. (2019). Successful implementation of a novel collaborative interprofessional educational curriculum for nurses and residents in a pediatric acute care setting. Journal of Interprofessional Education & Practice. 17. 100284–100284. 6 indexed citations
14.
Ortiz, Michael V., Kavitha Ramaswamy, Christopher J. Forlenza, et al.. (2018). Maintenance chemotherapy to reduce the risk of a metachronous Wilms tumor in children with bilateral nephroblastomatosis. Pediatric Blood & Cancer. 66(1). e27500–e27500. 5 indexed citations
15.
Campbell, Joyce, Michael V. Ortiz, Su‐Ting T. Li, Sarah Birch, & Dewesh Agrawal. (2016). Personal Digital Assistant-Based Self-Work Sampling Study of Pediatric Interns Quantifies Workday and Educational Value. Academic Pediatrics. 17(3). 288–295. 4 indexed citations
16.
Ortiz, Michael V., Emily Riehm Meier, & Matthew M. Hsieh. (2016). Identification and Clinical Characterization of Children With Benign Ethnic Neutropenia. Journal of Pediatric Hematology/Oncology. 38(3). e140–e143. 21 indexed citations
17.
Ortiz, Michael V. & Ira J. Dunkel. (2015). Retinoblastoma. Journal of Child Neurology. 31(2). 227–236. 80 indexed citations
18.
Wang, Honggui, Zenglin Zhang, Hongyu Li, et al.. (2013). CONSTANS-LIKE 7 regulates branching and shade avoidance response in Arabidopsis. Journal of Experimental Botany. 64(4). 1017–1024. 74 indexed citations
19.
Ortiz, Michael V., et al.. (2011). Impact of the Mirixa Program on Patient Compliance to Therapy. 30(3). 244. 2 indexed citations
20.
Ortiz, Michael V. & Ziad T. Awad. (2009). An Easy Technique for Laparoscopic Placement of Seprafilm. Surgical Laparoscopy Endoscopy & Percutaneous Techniques. 19(5). e181–e183. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026